Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

Alexandria Real Estate Equities, Inc. (ARE)

Real Estate Investment Trusts

https://www.are.com

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

26 NORTH EUCLID AVENUE
PASADENA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/28/1997

Market Cap

20,016,782,180

Shares Outstanding

173,780,000

Weighted SO

173,775,456

Total Employees

N/A

Upcoming Earnings

07/22/2024

Similar Tickers

Beta

1.1620

Last Div

5.2000

Range

90.73-135.45

Chg

-0.6100

Avg Vol

877045

Mkt Cap

20016782180

Exch

NYSE

Country

Phone

626-578-0777

DCF Diff

63.2022

DCF

56.0778

Div Yield

0.0444

P/S

6.6571

EV Multiple

14.7383

P/FV

1.0780

Div Yield %

4.4394

P/E

31.2972

PEG

1.8096

Payout

1.3880

Current Ratio

2.7785

Quick Ratio

2.7785

Cash Ratio

0.8409

DSO

2.8887

DIO

0.0000

Op Cycle

2.8887

DPO

71.0699

CCC

-68.1812

Gross Margin

0.2576

Op Margin

0.4520

Pretax Margin

0.2559

Net Margin

0.2092

Eff Tax Rate

-0.1524

ROA

0.0166

ROE

0.0341

ROCE

0.0366

NI/EBT

0.8173

EBT/EBIT

0.5663

EBIT/Rev

0.4520

Debt Ratio

0.3283

D/E

0.6804

LT Debt/Cap

0.4049

Total Debt/Cap

0.4049

Int Coverage

16.1361

CF/Debt

0.1287

Equity Multi

2.0729

Rec Turnover

126.3540

Pay Turnover

5.1358

Inv Turnover

0.0000

FA Turnover

4.3837

Asset Turnover

0.0794

OCF/Share

9.2985

FCF/Share

3.2793

Cash/Share

3.2896

OCF/Sales

0.5319

FCF/OCF

0.3527

CF Coverage

0.1287

ST Coverage

49983.1563

CapEx Coverage

1.5448

Div&CapEx Cov

0.8381

P/BV

1.0780

P/B

1.0780

P/S

6.6571

P/E

31.2972

P/FCF

35.4853

P/OCF

12.3063

P/CF

12.3063

PEG

1.8096

P/S

6.6571

EV Multiple

14.7383

P/FV

1.0780

DPS

5.0800

Latest Headlines (EST)

GlobeNewswire Inc. Apr 30, 21:00 Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update RARE GlobeNewswire Inc. Jan 17, 21:30 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) RARE GlobeNewswire Inc. Dec 14, 01:30 KBW Announces Index Rebalancing for Fourth-Quarter 2024 APO, APOS, APOpA, ARES, ARESpB, +20 more GlobeNewswire Inc. Nov 27, 22:00 American Rebel Holdings, Inc. Receives NASDAQ Notice AREB, AREBW GlobeNewswire Inc. Nov 09, 15:30 Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit RARE GlobeNewswire Inc. Sep 27, 20:45 AMERICAN REBEL ANNOUNCES 1-FOR-9 REVERSE STOCK SPLIT AREB, AREBW Zacks Investment Research Aug 09, 00:10 Denison Mine (DNN) Reports Q2 Loss, Tops Revenue Estimates DNN, AREC Seeking Alpha Jun 23, 15:00 Very Overrated And Very Underrated High Yield Sectors APO, ARCC, ARES, BAM, BEP, +17 more GlobeNewswire Inc. Jun 14, 00:49 Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants RARE The Motley Fool Jun 08, 18:58 3 Stocks to Buy With 20% Upside AMZN, JNJ, ARE GlobeNewswire Inc. May 28, 06:00 Ultragenyx lanceert Evkeeza® (evinacumab-concentraatoplossing voor infusie) in Nederland voor de behandeling van homozygote familiaire hypercholesterolemie (HoFH) RARE Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS Benzinga Jan 21, 15:33 RXR Launches $1 Billion Fund To Revive New York City's Office Building Market RMAX, ARES, RDFN, HOUS The Motley Fool Jan 20, 09:34 3 REITs to Buy, 1 REIT to Sell in 2024 VICI, MPW, ARE, REXR

Revenue Product Segmentation

Dividend History

Cash Value	Ex-Dividend Date	Declaration Date	Record Date	Pay Date
1.30	06/28/2024	06/03/2024	06/28/2024	07/15/2024
1.27	03/27/2024	03/04/2024	03/28/2024	04/15/2024
1.27	12/28/2023	12/04/2023	12/29/2023	01/12/2024
1.24	09/28/2023	09/05/2023	09/29/2023	10/13/2023
1.24	06/29/2023	06/05/2023	06/30/2023	07/14/2023
1.21	03/30/2023	03/06/2023	03/31/2023	04/14/2023
1.21	12/29/2022	12/05/2022	12/30/2022	01/13/2023
1.18	09/29/2022	09/06/2022	09/30/2022	10/14/2022
1.18	06/29/2022	05/31/2022	06/30/2022	07/15/2022
1.15	03/30/2022	03/01/2022	03/31/2022	04/15/2022
1.15	12/30/2021	12/06/2021	12/31/2021	01/14/2022
1.12	09/29/2021	09/07/2021	09/30/2021	10/15/2021
1.12	06/29/2021	06/01/2021	06/30/2021	07/15/2021
1.09	03/30/2021	03/01/2021	03/31/2021	04/15/2021
1.09	12/30/2020	12/07/2020	12/31/2020	01/15/2021
1.06	09/29/2020	09/01/2020	09/30/2020	10/15/2020
1.06	06/29/2020	06/01/2020	06/30/2020	07/15/2020
1.03	03/30/2020	03/02/2020	03/31/2020	04/15/2020
1.03	12/30/2019	12/05/2019	12/31/2019	01/15/2020
1.00	09/27/2019	09/04/2019	09/30/2019	10/15/2019
1.00	06/27/2019	06/03/2019	06/28/2019	07/15/2019
0.97	03/28/2019	03/04/2019	03/29/2019	04/15/2019
0.97	12/28/2018	12/03/2018	12/31/2018	01/15/2019
0.93	09/27/2018	09/04/2018	09/28/2018	10/15/2018
0.93	06/28/2018	06/04/2018	06/29/2018	07/16/2018
0.90	03/28/2018	03/05/2018	03/29/2018	04/16/2018
0.90	12/28/2017	12/01/2017	12/29/2017	01/15/2018
0.86	09/28/2017	09/01/2017	09/29/2017	10/16/2017
0.86	06/28/2017	06/05/2017	06/30/2017	07/17/2017
0.83	03/29/2017	03/08/2017	03/31/2017	04/17/2017
0.83	12/28/2016	12/05/2016	12/30/2016	01/17/2017
0.80	09/28/2016	09/06/2016	09/30/2016	10/17/2016
0.80	06/28/2016	06/06/2016	06/30/2016	07/15/2016
0.80	03/29/2016	03/07/2016	03/31/2016	04/15/2016
0.77	12/29/2015	12/08/2015	12/31/2015	01/15/2016
0.77	09/28/2015	09/14/2015	09/30/2015	10/15/2015
0.77	06/26/2015	06/08/2015	06/30/2015	07/15/2015
0.74	03/27/2015	03/16/2015	03/31/2015	04/15/2015
0.74	12/29/2014	12/01/2014	12/31/2014	01/15/2015
0.72	09/26/2014	09/15/2014	09/30/2014	10/15/2014
0.72	06/26/2014	06/16/2014	06/30/2014	07/15/2014
0.70	03/27/2014	03/17/2014	03/31/2014	04/15/2014
0.68	12/27/2013	12/11/2013	12/31/2013	01/15/2014
0.68	09/26/2013	09/10/2013	09/30/2013	10/15/2013
0.65	06/26/2013	06/13/2013	06/28/2013	07/15/2013
0.60	03/26/2013	03/14/2013	03/28/2013	04/15/2013
0.56	12/27/2012	11/27/2012	12/31/2012	01/15/2013
0.53	09/26/2012	09/10/2012	09/28/2012	10/15/2012
0.51	06/27/2012	06/12/2012	06/29/2012	07/16/2012
0.49	03/28/2012	03/08/2012	03/30/2012	04/13/2012
0.49	12/28/2011	12/01/2011	12/30/2011	01/17/2012
0.47	09/28/2011	09/14/2011	09/30/2011	10/17/2011
0.45	06/28/2011	06/14/2011	06/30/2011	07/15/2011
0.45	03/29/2011	03/22/2011	03/31/2011	04/15/2011
0.45	12/29/2010	11/29/2010	12/31/2010	01/17/2011
0.35	09/29/2010	09/14/2010	10/01/2010	10/15/2010
0.35	06/29/2010	06/14/2010	07/01/2010	07/15/2010
0.35	03/30/2010	03/16/2010	04/01/2010	04/15/2010
0.35	12/29/2009	12/15/2009	12/31/2009	01/15/2010
0.35	09/29/2009	09/15/2009	10/01/2009	10/15/2009
0.35	06/29/2009	04/21/2009	07/01/2009	07/15/2009
0.80	03/30/2009	03/16/2009	04/01/2009	04/15/2009
0.80	12/30/2008	12/11/2008	01/02/2009	01/15/2009
0.80	09/26/2008	09/19/2008	09/30/2008	10/15/2008
0.80	06/27/2008	06/17/2008	07/01/2008	07/15/2008
0.78	03/28/2008	03/20/2008	04/01/2008	04/15/2008
0.78	12/28/2007	12/13/2007	01/02/2008	01/15/2008
0.76	09/27/2007	09/19/2007	10/01/2007	10/15/2007
0.76	06/28/2007	06/18/2007	07/02/2007	07/13/2007
0.74	03/29/2007	03/23/2007	04/02/2007	04/13/2007
0.74	12/28/2006	12/13/2006	01/02/2007	01/15/2007
0.72	09/28/2006	09/22/2006	10/02/2006	10/13/2006
0.70	06/29/2006	06/23/2006	07/03/2006	07/14/2006
0.70	03/30/2006	03/24/2006	04/03/2006	04/14/2006
0.70	12/28/2005	12/08/2005	01/02/2006	01/13/2006
0.68	09/29/2005	09/20/2005	10/03/2005	10/14/2005
0.68	06/29/2005	06/20/2005	07/01/2005	07/15/2005
0.66	03/30/2005	03/18/2005	04/01/2005	04/15/2005
0.66	12/30/2004	12/10/2004	01/03/2005	01/14/2005
0.64	09/29/2004	09/22/2004	10/01/2004	10/15/2004
0.62	06/30/2004	06/21/2004	07/02/2004	07/15/2004
0.60	03/31/2004	03/16/2004	04/02/2004	04/15/2004
0.58	12/30/2003	12/12/2003	01/02/2004	01/15/2004
0.56	09/29/2003	09/10/2003	10/01/2003	10/15/2003
0.53	07/01/2003	06/27/2003	07/03/2003	07/14/2003
0.53	03/28/2003	03/14/2003	04/01/2003	04/11/2003
0.50	12/31/2002	12/10/2002	01/03/2003	01/13/2003
0.50	10/02/2002	09/17/2002	10/04/2002	10/15/2002
50.00	07/02/2002	06/25/2002	07/05/2002	07/15/2002
50.00	04/03/2002	03/11/2002	04/05/2002	04/15/2002
46.00	01/02/2002	12/11/2001	01/04/2002	01/15/2002
46.00	10/03/2001	09/25/2001	10/05/2001	10/15/2001
46.00	07/03/2001	06/20/2001	07/06/2001	07/16/2001
46.00	04/04/2001	03/27/2001	04/06/2001	04/16/2001
43.00	01/02/2001	12/04/2000	01/04/2001	01/15/2001
43.00	10/03/2000	09/25/2000	10/05/2000	10/16/2000
43.00	06/30/2000	06/16/2000	07/05/2000	07/14/2000
43.00	03/31/2000	03/21/2000	04/04/2000	04/14/2000
43.00	12/31/1999	12/06/1999	01/04/2000	01/14/2000
43.00	10/01/1999	09/24/1999	10/05/1999	10/15/1999
43.00	06/30/1999	06/29/1999	07/02/1999	07/15/1999
40.00	03/30/1999	03/16/1999	04/01/1999	04/12/1999
40.00	12/31/1998	12/02/1998	01/05/1999	01/15/1999
40.00	10/02/1998	09/29/1998	10/06/1998	10/16/1998
40.00	07/02/1998	06/01/1998	07/07/1998	07/17/1998
40.00	04/03/1998	03/04/1998	04/07/1998	04/17/1998
40.00	01/07/1998	12/17/1997	01/09/1998	01/16/1998
40.00	10/08/1997	09/25/1997	10/10/1997	10/17/1997
12.75	07/02/1997	06/30/1997	07/07/1997	07/18/1997

Year	Purchases	Sales	Total Bought	Total Sold

Transaction Date	Name	Type Of Owner	Price	Securities Owned	Securities Transacted	Security Name	Transaction Type

Less Than 3 Months

413.00 Shares Bought (1.02 %)

40.16K Shares Sold (98.98%)

3 - 6 Months

242.42K Shares Bought (90.25 %)

26.19K Shares Sold (9.75%)

6 - 9 Months

311.79K Shares Bought (81.97 %)

68.59K Shares Sold (18.03%)

9 - 12 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0 %)

Investor Name	Investment Discretion	Type of Security	Shares Owned	Avg Price Paid	Market Value	Change In Market Value	Change In Market Value (%)	Ownership	Weight

Date	Investors Holding	Closed Positions	Increased Positions	Reduced Positions	New Positions	Total Invested	Put/Call Ratio	Total Calls	Total Puts

Owner	Shares Owned

	2019	2020	2021	2022	2023	2024	2024
Revenue	340.46M	▲ 408.11M	▲ 463.72M	▲ 576.92M	▲ 670.28M	▲ 757.22M	▲ 769.11M
Cost Of Revenue	97.68M	▲ 121.85M	▲ 136.77M	▲ 175.72M	▲ 204.35M	▲ 979.94M	▼ 505.87M
Gross Profit	242.78M	▲ 286.26M	▲ 326.95M	▲ 401.21M	▲ 465.93M	▼ -222.73M	▲ 263.24M
Gross Profit Ratio	0.71	▼ 0.70	▲ 0.71	▼ 0.70	▼ 0.70	▼ -0.29	▲ 0.34
Research And Development Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General And Administrative Expenses	22.39M	▲ 29.78M	▲ 32.69M	▲ 41.65M	▲ 42.99M	▲ 59.29M	▼ 47.06M
Selling And Marketing Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling General And Administrative Expenses	22.39M	▲ 29.78M	▲ 32.69M	▲ 41.65M	▲ 42.99M	▲ 59.29M	▼ 47.06M
Other Expenses	124.99M	▲ 140.52M	▲ 177.75M	▲ 239.25M	▲ 264.48M	▼ -39.81M	▲ -17.90M
Operating Expenses	147.38M	▲ 170.30M	▲ 210.44M	▲ 280.91M	▲ 307.47M	▼ -757.22M	▲ 17.90M
Cost And Expenses	245.06M	▲ 292.15M	▲ 347.21M	▲ 456.63M	▲ 511.82M	▼ 222.73M	▲ 523.77M
Interest Income	0.00	0.00	0.00	0.00	▲ 17.52M	▼ -42.24M	▲ 0.00
Interest Expense	40.24M	▲ 45.49M	▼ 37.54M	▼ 34.86M	▼ 17.52M	▲ 31.97M	▲ 40.84M
Depreciation And Amortization	124.99M	▲ 140.52M	▲ 177.75M	▲ 239.25M	▲ 264.48M	▼ 261.56M	▲ 287.55M
Ebitda	221.43M	▲ 261.26M	▲ 297.86M	▲ 362.57M	▲ 423.11M	▲ 534.49M	▼ 532.90M
Ebitda Ratio	0.65	▼ 0.64	▲ 0.64	▼ 0.63	▲ 0.63	▲ 0.71	▼ 0.69
Operating Income	15.56M	▲ 247.93M	▲ 479.02M	▼ 109.76M	▲ 158.63M	▲ 534.49M	▼ 245.34M
Operating Income Ratio	0.05	▲ 0.61	▲ 1.03	▼ 0.19	▲ 0.24	▲ 0.71	▼ 0.32
Total Other Income Expenses Net	-73.80M	▲ 145.58M	▲ 378.16M	▼ 14.36M	▼ -63.36M	▼ -143.30M	▲ 17.12M
Income Before Tax	-18.63M	▲ 216.05M	▲ 457.13M	▼ 99.80M	▼ 95.27M	▲ 391.19M	▼ 262.46M
Income Before Tax Ratio	-0.05	▲ 0.53	▲ 0.99	▼ 0.17	▼ 0.14	▲ 0.52	▼ 0.34
Income Tax Expense	6.05M	▲ 13.61M	▲ 15.65M	▲ 24.90M	▼ 17.52M	▼ -261.56M	▲ 95.57M
Net Income	-24.68M	▲ 202.44M	▲ 441.48M	▼ 74.90M	▲ 77.75M	▲ 391.19M	▼ 170.55M
Net Income Ratio	-0.07	▲ 0.50	▲ 0.95	▼ 0.13	▼ 0.12	▲ 0.52	▼ 0.22
Eps	-0.23	▲ 1.75	▲ 3.26	▼ 0.47	0.47	▲ 2.29	▼ 0.97
Eps Diluted	-0.23	▲ 1.74	▲ 3.26	▼ 0.47	0.47	▲ 2.29	▼ 0.97
Weighted Average Shs Out	105.07M	▲ 114.18M	▲ 133.69M	▲ 153.46M	▲ 165.39M	▲ 171.10M	▲ 171.95M
Weighted Average Shs Out Dil	106.03M	▲ 114.97M	▲ 133.83M	▲ 154.31M	▲ 165.39M	▲ 171.10M	▲ 171.95M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View

	2019	2020	2021	2022	2023	2024	2024
Cash And Cash Equivalents	234.18M	▼ 189.68M	▲ 568.53M	▼ 361.35M	▲ 825.19M	▼ 618.19M	▲ 731.70M
Short Term Investments	0.00	0.00	0.00	▲ 24.98B	▼ 1.62B	▼ 0.00	0.00
Cash And Short Term Investments	234.18M	▼ 189.68M	▲ 568.53M	▼ 361.35M	▲ 825.19M	▼ 618.19M	▲ 731.70M
Net Receivables	9.80M	▲ 10.69M	▼ 7.33M	▲ 7.38M	▲ 7.61M	▲ 64.15M	▼ 23.96M
Inventory	-26.66M	▼ -42.35M	▼ -81.53M	▼ -200.88M	▲ -49.10M	▲ 784.24M	▼ 0.00
Other Current Assets	64.61M	▲ 95.36M	▲ 110.70M	▲ 254.76M	▼ 81.88M	▼ -684.82M	▼ -755.65M
Total Current Assets	281.93M	▼ 253.38M	▲ 605.04M	▼ 422.61M	▲ 865.59M	▼ 781.75M	▲ 877.31M
Property Plant Equipment Net	228.72M	▲ 743.68M	▲ 982.99M	▲ 1.26B	▲ 1.35B	▼ 1.15B	▼ 685.61M
Goodwill	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.00	▲ 615.64M	▼ 461.61M	▼ 426.67M
Goodwill And Intangible Assets	0.00	0.00	0.00	0.00	▲ 615.64M	▼ 461.61M	▼ 426.67M
Long Term Investments	1.13B	▲ 1.49B	▲ 1.94B	▼ 1.92B	▼ 1.65B	▼ 1.49B	▲ 1.55B
Tax Assets	0.00	0.00	0.00	0.00	▼ -615.64M	▲ -461.61M	▲ -426.67M
Other Non Current Assets	12.82B	▲ 15.91B	▲ 19.30B	▲ 26.62B	▲ 31.66B	▲ 33.35B	▲ 34.58B
Total Non Current Assets	14.18B	▲ 18.14B	▲ 22.22B	▲ 29.80B	▲ 34.66B	▲ 35.99B	▲ 36.82B
Other Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	14.46B	▲ 18.39B	▲ 22.83B	▲ 30.22B	▲ 35.52B	▲ 36.77B	▲ 37.70B
Account Payables	981.71M	▲ 1.32B	▲ 1.67B	▲ 2.21B	▲ 2.47B	▼ 524.44M	▼ 432.30M
Short Term Debt	208.00M	▲ 384.00M	▼ 99.99M	▲ 269.99M	▲ 350.04M	▼ 99.95M	▼ 32.00K
Tax Payables	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Revenue	250.92M	▲ 275.86M	▲ 276.75M	▲ 326.92M	▲ 449.62M	▲ 548.53M	▲ 561.80M
Other Current Liabilities	-140.64M	▼ -149.59M	▲ -125.77M	▼ -143.08M	▼ -590.53M	▲ 828.16M	▲ 865.56M
Total Current Liabilities	1.30B	▲ 1.83B	▲ 1.92B	▲ 2.66B	▲ 2.68B	▼ 2.00B	▼ 1.86B
Long Term Debt	5.27B	▲ 6.39B	▲ 7.46B	▲ 8.52B	▲ 10.16B	▲ 11.60B	▲ 12.22B
Deferred Revenue Non Current	250.92M	▲ 275.86M	▲ 276.75M	▼ 0.00	▲ 18.32M	▼ 15.18M	▼ 13.37M
Deferred Tax Liabilities Non Current	-449.63M	▼ -556.71M	▼ -654.23M	▲ 0.00	▼ -1.86B	▲ -15.18M	▼ -1.19B
Other Non Current Liabilities	198.71M	▲ 280.85M	▲ 377.47M	▼ 0.00	▲ 1.84B	▼ 548.76M	▲ 2.04B
Total Non Current Liabilities	5.27B	▲ 6.39B	▲ 7.46B	▲ 8.52B	▲ 10.16B	▲ 12.15B	▲ 13.08B
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital Lease Obligations	134.81M	▲ 271.81M	▲ 345.75M	▲ 434.75M	▼ 406.70M	▼ 382.88M	▲ 672.19M
Total Liabilities	6.57B	▲ 8.22B	▲ 9.38B	▲ 11.19B	▲ 12.84B	▲ 14.15B	▲ 14.94B
Preferred Stock	64.34M	▼ 0.00	0.00	0.00	0.00	0.00	0.00
Common Stock	1.11M	▲ 1.21M	▲ 1.37M	▲ 1.58M	▲ 1.71M	▲ 1.72M	▲ 1.72M
Retained Earnings	0.00	0.00	0.00	▲ 1.23B	▲ 2.51B	▼ 0.00	0.00
Accumulated Other Comprehensive Income Loss	-10.44M	▲ -9.75M	▲ -6.63M	▼ -7.29M	▼ -20.81M	▲ -15.90M	▼ -23.82M
Other Total Stockholders Equity	7.29B	▲ 8.87B	▲ 11.73B	▲ 14.97B	▲ 16.48B	▲ 18.49B	▼ 18.43B
Total Stockholders Equity	7.34B	▲ 8.87B	▲ 11.73B	▲ 16.19B	▲ 18.97B	▼ 18.47B	▼ 18.41B
Total Equity	7.34B	▲ 8.87B	▲ 11.73B	▲ 16.19B	▲ 22.68B	▼ 22.62B	▲ 22.76B
Total Liabilities And Stockholders Equity	14.46B	▲ 18.39B	▲ 22.83B	▲ 30.22B	▲ 35.52B	▲ 36.77B	▲ 37.70B
Minority Interest	552.75M	▲ 1.30B	▲ 1.72B	▲ 2.84B	▲ 3.71B	▲ 4.15B	▲ 4.34B
Total Liabilities And Total Equity	14.46B	▲ 18.39B	▲ 22.83B	▲ 30.22B	▲ 35.52B	▲ 36.77B	▲ 37.70B
Total Investments	1.13B	▲ 1.49B	▲ 1.94B	▲ 26.90B	▼ 1.65B	▼ 1.49B	▲ 1.55B
Total Debt	5.48B	▲ 6.78B	▲ 7.56B	▲ 8.79B	▲ 10.16B	▲ 11.70B	▲ 12.89B
Net Debt	5.24B	▲ 6.59B	▲ 6.99B	▲ 8.43B	▲ 9.33B	▲ 11.08B	▲ 12.16B
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View

	2019	2020	2021	2022	2023	2024	2024
Net Income	-18.63M	▲ 216.05M	▲ 457.13M	▼ 99.80M	▼ 95.27M	▼ -42.66M	▲ 166.89M
Depreciation And Amortization	124.99M	▲ 140.52M	▲ 177.75M	▲ 239.25M	▲ 244.36M	▲ 261.56M	▲ 287.55M
Deferred Income Tax	73.80M	▼ -145.40M	▼ -375.97M	▲ -9.59M	▲ 0.00	▲ 201.31M	▼ 1.65M
Stock Based Compensation	9.81M	▲ 10.24M	▲ 11.39M	▲ 14.25M	▼ 11.59M	▲ 34.59M	▼ 17.13M
Change In Working Capital	-12.23M	▲ -11.22M	▼ -61.37M	▲ -54.88M	▲ 23.61M	▼ 11.03M	▼ -65.62M
Accounts Receivables	1.24M	▼ -11.00K	▲ 318.00K	▲ 371.00K	▼ 149.00K	▼ -1.30M	▲ 731.00K
Inventory	780.00K	▼ -15.84M	▲ -4.90M	▲ 2.72M	▼ 0.00	▲ 21.71M	▼ 0.00
Accounts Payables	12.00K	▲ 24.71M	▼ -31.00M	▲ -1.39M	▲ 56.79M	▼ 18.39M	▼ -1.65M
Other Working Capital	-14.27M	▼ -20.08M	▼ -25.79M	▼ -56.59M	▲ -33.33M	▲ -27.77M	▼ -64.70M
Other Non Cash Items	-21.48M	▼ -31.90M	▼ -35.37M	▼ -39.27M	▲ 26.35M	▼ -37.22M	▲ 528.37M
Net Cash Provided By Operating Activities	156.25M	▲ 178.29M	▼ 173.57M	▲ 249.56M	▲ 401.16M	▲ 428.62M	▼ 341.16M
Investments In Property Plant And Equipment	-339.21M	▼ -1.27B	▲ 855.91M	▼ -2.10B	▲ 0.00	▼ -391.29M	▲ 0.00
Acquisitions Net	-38.51M	▲ -2.11M	▲ -153.00K	▲ 382.03M	▼ -197.00K	▲ -159.00K	▲ 82.85M
Purchases Of Investments	-61.75M	▲ -56.91M	▼ -58.29M	▼ -89.49M	▲ -56.24M	▲ -33.11M	▼ -952.07M
Sales Maturities Of Investments	46.35M	▼ 44.13M	▼ 37.48M	▲ 146.07M	▼ 48.65M	▼ 34.10M	▲ 57.22M
Other Investing Activities	-4.50M	▲ -1.90M	▼ -1.25B	▲ -14.28M	▼ -1.35B	▲ 400.00K	▼ -1.01M
Net Cash Used For Investing Activities	-397.61M	▼ -1.29B	▲ -413.15M	▼ -1.67B	▲ -1.36B	▲ -390.06M	▼ -812.00M
Debt Repayment	-206.73M	▲ 39.26M	▼ -112.23M	▲ 9.13M	▼ -3.37B	▲ -110.38M	▼ -898.90M
Common Stock Issued	0.00	0.00	0.00	0.00	▲ 1.50B	▼ 103.85M	▼ 0.00
Common Stock Repurchased	0.00	▼ -327.00K	▼ -5.09M	▼ -10.84M	▼ -14.18M	▲ -4.39M	▼ -23.96M
Dividends Paid	-101.30M	▼ -115.57M	▼ -143.04M	▼ -173.56M	▼ -193.62M	▼ -214.45M	▼ -221.82M
Other Financing Activities	588.66M	▲ 978.45M	▼ 611.93M	▲ 1.65B	▲ 3.03B	▼ 55.42M	▼ -135.50M
Net Cash Used Provided By Financing Activities	280.63M	▲ 901.81M	▼ 351.58M	▲ 1.47B	▼ 950.75M	▼ 55.19M	▲ 541.58M
Effect Of Forex Changes On Cash	-1.02M	▲ 72.00K	▲ 663.00K	▼ -2.05M	▲ -263.00K	▼ -688.00K	▲ 192.00K
Net Change In Cash	38.25M	▼ -210.28M	▲ 112.66M	▼ 47.17M	▼ -8.19M	▲ 93.06M	▼ 70.92M
Cash At End Of Period	272.13M	▼ 242.69M	▲ 597.71M	▼ 415.23M	▲ 857.98M	▼ 660.77M	▲ 731.70M
Cash At Beginning Of Period	233.88M	▲ 452.97M	▲ 485.04M	▼ 368.05M	▲ 866.17M	▼ 567.71M	▲ 660.77M
Operating Cash Flow	156.25M	▲ 178.29M	▼ 173.57M	▲ 249.56M	▲ 401.16M	▲ 428.62M	▼ 341.16M
Capital Expenditure	-339.21M	▼ -1.27B	▲ 855.91M	▼ -2.10B	▲ 0.00	▼ -391.29M	▲ 0.00
Free Cash Flow	-182.95M	▼ -1.10B	▲ 1.03B	▼ -1.85B	▲ 401.16M	▼ 37.33M	▲ 341.16M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View